Search research articles
Contact Us
Filters
Showing results (81-90 of 176) with videos related to
Page
of 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2013
CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma
Ohad Benjamini, Preetesh Jain, Sergej N Konoplev, et al.
American Journal of Hematology
|
February 17, 2015
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome
Preetesh Jain, Michael Keating, Phillip A Thompson, et al.
Leukemia & Lymphoma
|
February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia
Uri Rozovski, David M Harris, Ping Li, et al.
Immunologic Research
|
October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
Barbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Oncotarget
|
September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2016
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal Dysfunction
Koji Sasaki, Amit Lahoti, Elias Jabbour, et al.
Oncotarget
|
May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 8, 2016
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia
Koji Sasaki, Elias Jabbour, Jorge Cortes, et al.
The Lancet. Haematology
|
October 6, 2015
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study
Preetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
British Journal of Haematology
|
August 4, 2017
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors
Preetesh Jain, Rashmi Kanagal-Shamanna, F Anthony San Lucas, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 176) with videos related to
Sort By:
Page
of 18
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2013
CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma
Ohad Benjamini, Preetesh Jain, Sergej N Konoplev, et al.
American Journal of Hematology
|
February 17, 2015
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome
Preetesh Jain, Michael Keating, Phillip A Thompson, et al.
Leukemia & Lymphoma
|
February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia
Uri Rozovski, David M Harris, Ping Li, et al.
Immunologic Research
|
October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
Barbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Oncotarget
|
September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2016
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal Dysfunction
Koji Sasaki, Amit Lahoti, Elias Jabbour, et al.
Oncotarget
|
May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 8, 2016
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia
Koji Sasaki, Elias Jabbour, Jorge Cortes, et al.
The Lancet. Haematology
|
October 6, 2015
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study
Preetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
British Journal of Haematology
|
August 4, 2017
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors
Preetesh Jain, Rashmi Kanagal-Shamanna, F Anthony San Lucas, et al.
Page
of 18